Oral Anticoagulants in Cancer Patients: Mixed-Results and a Lesson about Trial Enrichment

Oral Anticoagulants in Cancer Patients: Mixed-Results and a Lesson about Trial Enrichment

Two studies in the New England Journal of Medicine came to differing conclusions about the utility of oral anticoagulants in patients with cancer. This might be because they enrolled the wrong patients.

Read More

Research and Development Costs and Drug Pricing: Link Tenuous at Best

Research and Development Costs and Drug Pricing: Link Tenuous at Best

A study appearing in JAMA Internal Medicine links the cost of developing a new drug to the ultimate revenue a company receives. The results suggest that curbing R&D costs may not have much effect on drug pricing at all. For the video version, click here.

Read More